Public Health Institute (PHI)
Ms. Coeytaux is internationally known for her promotion of comprehensive reproductive health services, safe abortion services, and the development of new reproductive technologies. In her thirty-year career she has worked to empower women, particularly in managing their reproductive health and rights, and has pioneered the use of acceptability research to give voice to women in the shaping of public health agendas.
There is much we can learn from our sisters in the Global South who, rather than trying to gain access to services that all too often do not exist or fail to treat them well, are obtaining pills to induce abortion and taking them at home without seeing a health provider.
We applaud the California governor’s veto of AB 926, which would have permitted researchers to pay women for their eggs. His decision was based, in part, on the fact that the risks to women who provide eggs outweigh the potential scientific benefits.
Misoprostol Is a Game-Changer for Safe Abortion and Maternal Health Care. Why Isn’t it More Widely Available?
If we have a cheap and readily available drug that can prevent and treat the two largest causes of maternal mortality worldwide—postpartum hemorrhage and unsafe abortion—why have we not taken more advantage of it?
As we prepare to honor our mothers, I am struck by the difference between my mother’s childbearing experiences and my own. I had many choices; she had few.